Hypometabolism as a therapeutic target in Alzheimer's disease

被引：98

作者：

Costantini, Lauren C. ^{[1
]}

Barr, Linda J. ^{[1
]}

Vogel, Janet L. ^{[1
]}

Henderson, Samuel T. ^{[1
]}

机构：

[1] Accera Inc, Interlocken Crescent, Broomfield, CO 80021 USA

来源：

BMC NEUROSCIENCE | 2008年 / 9卷 / Suppl 2期

关键词：

D O I：

10.1186/1471-2202-9-S2-S16

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The pathology of Alzheimer's disease ( AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. This decline in cerebral glucose metabolism occurs before pathology and symptoms manifest, continues as symptoms progress, and is more severe than that of normal aging. Ketone bodies are an efficient alternative fuel for cells that are unable to metabolize glucose or are 'starved' of glucose. AC-1202 is designed to elevate serum ketone levels safely. We previously showed that treatment with AC-1202 in patients with mild-to-moderate AD improves memory and cognition. Treatment outcomes were influenced by apolipoprotein E genotype status. These data suggest that AC-1202 may be an effective treatment for cognitive dysfunction by providing an alternative substrate for use by glucose-compromised neurons.

引用

页数：9

共 58 条

[11] Aspects of neurodegeneration in the canine brain [J].

Dimakopoulos, AC ;

Mayer, RJ .

JOURNAL OF NUTRITION, 2002, 132 (06) :1579S-1582S

[12] Ketone bodies stimulate chaperone-mediated autophagy [J].

Finn, PF ;

Dice, JF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25864-25870

[13] Untitled [J].

Freeman, JM ;

Vining, EPG .

EPILEPSIA, 1998, 39 (04) :450-451

[14] The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid [J].

Gasior, Maciej ;

French, Amy ;

Joy, Michelle T. ;

Tang, Rebecca S. ;

Hartman, Adam L. ;

Rogawski, Michael A. .

EPILEPSIA, 2007, 48 (04) :793-800

[15] GLUCOSE ENHANCEMENT OF PERFORMANCE ON MEMORY TESTS IN YOUNG AND AGED HUMANS [J].

HALL, JL ;

GONDERFREDERICK, LA ;

CHEWNING, WW ;

SILVEIRA, J ;

GOLD, PE .

NEUROPSYCHOLOGIA, 1989, 27 (09) :1129-1138

[16] Oxidative damage increases with age in a canine model of human brain aging [J].

Head, E ;

Liu, J ;

Hagen, TM ;

Muggenburg, BA ;

Milgram, NW ;

Ames, BN ;

Cotman, CW .

JOURNAL OF NEUROCHEMISTRY, 2002, 82 (02) :375-381

[17] The ketogenic diet: A 3-to 6-year follow-up of 150 children enrolled prospectively [J].

Hemingway, C ;

Freeman, JM ;

Pillas, DJ ;

Pyzik, PL .

PEDIATRICS, 2001, 108 (04) :898-905

[18] High carbohydrate diets and Alzheimer's disease [J].

Henderson, ST .

MEDICAL HYPOTHESES, 2004, 62 (05) :689-700

[19] Lack of association of apolipoprotein E ε4 allele dose with cerebral glucose metabolism in Alzheimer disease [J].

Hirono, N ;

Mori, E ;

Yasuda, M ;

Ishii, K ;

Ikejiri, Y ;

Imamura, T ;

Shimomura, T ;

Hashimoto, M ;

Yamashita, H ;

Sasaki, M .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (04) :362-367

[20] The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset [J].

Hirono, N ;

Hashimoto, M ;

Yasuda, M ;

Ishii, K ;

Sakamoto, S ;

Kazui, H ;

Mori, E .

NEUROLOGY, 2002, 58 (05) :743-750

← 1 2 3 4 5 6 →